KL and chronic kidney disease: Since indoxyl sulfate may play a significant role in the vascular disease and higher mortality observed in CKD patients [37], epigenetic modification of the Klotho gene by a uremic toxin such as indoxyl sulfate might be a mechanism underlying the association between the decline of serum Klotho levels and arterial stiffness in CKD patients observed in the current study.